<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087552</url>
  </required_header>
  <id_info>
    <org_study_id>18072011</org_study_id>
    <nct_id>NCT03087552</nct_id>
  </id_info>
  <brief_title>Mini-invasive Balloon Aortic Valvuloplasty</brief_title>
  <acronym>SOFTLY-II</acronym>
  <official_title>Safety and Feasibility of Transradial Mini-invasive Balloon Aortic Valvuloplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Ferrara</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The spreading of transcatheter aortic valve implantation has paradoxically increased the
      spectrum of indications for balloon aortic valvuloplasty. Balloon aortic valvuloplasty is
      currently used as destination therapy for patients excluded from transcatheter aortic valve
      implantation, as bridge to transcatheter aortic valve implantation or to surgical aortic
      valve replacement, or as a stratification tool for selected high-risk patients who cannot be
      immediate candidates for transcatheter aortic valve implantation. Moreover, it has been
      recently showed that transcatheter aortic valve implantation without balloon aortic
      valvuloplasty is encumbered by an increased risk of cerebral embolization. However, balloon
      aortic valvuloplasty has a complication rate comparable to transcatheter aortic valve
      implantation, mainly related to access site or temporary pacemaker implantation. Thus, a
      transradial mini-invasive approach with rapid pacing through the 0,035 inch left ventricular
      support wire could be extremely appealing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients with severe aortic stenosis with indication to aortic balloon
      valvuloplasty will be enrolled. An ad hoc informed consent for the procedure will be obtained
      from all patients.

      This is a prospective observational study. The Investigators will include patients where
      aortic ballloon valvuloplasty is attempted by radial access and without temporary pacemaker
      implantation. The aim is to register and monitor the effectiveness and safety of this
      approach. Details regarding management of radial access and pacing with 0.035 wire can be
      found in the references reported below. The primary endpoint will be the 30-day occurence of
      minor and major vascular complications according VARC 2 classification. The safety endpoint
      will be the absence of intra- or periprocedural major complications in transradial balloon
      aortic valvuloplasty, namely balloon entrapment or compartment syndrome requiring surgical
      intervention.

      The feasibility endpoint will be a procedural success rate â‰¥90%. The efficacy endpoint will
      be a reduction of the mean invasive gradient &gt;30%. At baseline, Handgrip strength test will
      be performed and angiography of the instrumented arm will be performed at the beginning and
      at the end of the procedure. All patients will be prospectively followed-up for at least 30
      days and all adverse events will be recorded. All patients will be assessed also for frailty
      according the clinical frailty scale (CFS). During the 30-day follow-up visit two independent
      blinded operators will evaluate radial artery patency by ultrasonography and perform handgrip
      strength test in in both arms in all patients.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 11, 2017</start_date>
  <completion_date type="Anticipated">January 10, 2021</completion_date>
  <primary_completion_date type="Actual">January 7, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Vascular complications</measure>
    <time_frame>1 month</time_frame>
    <description>Cumulative occurrence of major and minor bleeding complications according the VARC-2 classification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transradial balloon aortic valvuloplasty major complications</measure>
    <time_frame>1 month</time_frame>
    <description>Balloon entrapment, compartment syndrome requiring surgical intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 month</time_frame>
    <description>Cumulative occurrence of death, stroke, coronary occlusion, coronary dissection, moderate-severe aortic regurgitation, severe hypotension requiring intervention, pericardiocentesis, definitive pace-maker implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major vascular complications</measure>
    <time_frame>1 month</time_frame>
    <description>Cumulative occurrence of major bleeding complications according the VARC-2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minor vascular complications</measure>
    <time_frame>1 month</time_frame>
    <description>Cumulative occurrence of minor bleeding complications according the VARC-2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radial artery occlusion</measure>
    <time_frame>1 month</time_frame>
    <description>Cumulative occurrence of radial artery occlusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radial artery occlusion</measure>
    <time_frame>24 hours</time_frame>
    <description>Cumulative occurrence of radial artery occlusion</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Frailty assessment</measure>
    <time_frame>1 month</time_frame>
    <description>Improvement from baseline to 1 month of the Clinical Frailty Scale. The Clinical Frailty Scale (CFS) ranges from 1 to 9, with higher values suggestive for poor prognosis</description>
  </other_outcome>
  <other_outcome>
    <measure>Physical performance assessment</measure>
    <time_frame>1 month</time_frame>
    <description>Improvement from baseline to 1 month of grip strength</description>
  </other_outcome>
  <other_outcome>
    <measure>Essential Frailty Toolset</measure>
    <time_frame>1 month</time_frame>
    <description>Improvement from baseline to 1 month of the value of the Essential Frailty Toolset scale. The Essential Frailty Toolset (EFT) ranges from 0 to 5, with higher values suggestive for poor prognosis</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">361</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Transradial balloon aortic valvuloplasty</arm_group_label>
    <description>Consecutive patients with severe aortic stenosis and receiving as first attempt balloon aortic valvuloplasty by transradial access.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transradial balloon aortic valvuloplasty</intervention_name>
    <description>Mini-invasive balloon aortic valvuloplasty consisting in transradial access</description>
    <arm_group_label>Transradial balloon aortic valvuloplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transradial balloon aortic valvuloplasty</intervention_name>
    <description>Rapid pacing using the 0.035-in. retrograde left ventricular support wire</description>
    <arm_group_label>Transradial balloon aortic valvuloplasty</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with severe aortic stenosis with indication to balloon aortic valvuloplasty
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  severe symptomatic aortic stenosis requiring balloon aortic valvuloplasty

        Exclusion Criteria:

          -  cardiogenic shock

          -  bilateral absence of radial pulse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Ferrara</name>
      <address>
        <city>Cona</city>
        <state>Ferrara</state>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pia Fondazione Panico</name>
      <address>
        <city>Tricase</city>
        <state>Lecce</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Bassini</name>
      <address>
        <city>Cinisello Balsamo</city>
        <state>Milano</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AOU San Luigi Gonzaga</name>
      <address>
        <city>Orbassano</city>
        <state>Torino</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Conegliano</name>
      <address>
        <city>Conegliano</city>
        <state>Treviso</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AOU di Ancona</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AOU di Bologna</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Morgagni Pierantoni</name>
      <address>
        <city>ForlÃ¬</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Misericordia</name>
      <address>
        <city>Grosseto</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Santo Spirito</name>
      <address>
        <city>Pescara</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria delle Croci</name>
      <address>
        <city>Ravenna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale degli Infermi</name>
      <address>
        <city>Rimini</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni di Dio e Ruggi d'Aragona</name>
      <address>
        <city>Salerno</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Sassari</name>
      <address>
        <city>Sassari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASL di Teramo</name>
      <address>
        <city>Teramo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale degli Infermi di Rivoli</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Tumscitz C, Pirani L, Tebaldi M, Campo G, Biscaglia S. Seven french radial artery access for PCI: a prospective single-center experience. Int J Cardiol. 2014 Oct 20;176(3):1074-5. doi: 10.1016/j.ijcard.2014.07.134. Epub 2014 Aug 2.</citation>
    <PMID>25127334</PMID>
  </reference>
  <reference>
    <citation>Hilling-Smith R, Cockburn J, Dooley M, Parker J, Newton A, Hill A, Trivedi U, de Belder A, Hildick-Smith D. Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2017 Mar 1;89(4):783-786. doi: 10.1002/ccd.26720. Epub 2016 Oct 11.</citation>
    <PMID>27726292</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 11, 2017</study_first_submitted>
  <study_first_submitted_qc>March 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Ferrara</investigator_affiliation>
    <investigator_full_name>Gianluca Campo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

